The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes patients across ten countries across the world. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than prescribed to them by their doctor. Participants' participation will be one day/one visit at their doctor. The study will last for about 6 months in total.
No specific intervention is studied. All anti-diabetic and CV medication will be prescribed at the physician's discretion under routine clinical practice conditions.
Buenos Aires, Argentina
Buenos Aires, Argentina
Buenos Aires, Argentina
Buenos Aires, Argentina
CABA, Argentina
CABA, Argentina
CABA, Argentina
Chacabuco, Argentina
Coronel Suárez, Argentina
Córdoba, Argentina
Córdoba, Argentina
Córdoba, Argentina
Córdoba, Argentina
Godoy Cruz, Argentina
Lanús Este, Argentina
Mar del Plata, Argentina
Mar del Plata, Argentina
Morón, Argentina